Synopsis
Featuring community-based medical oncologists presenting actual de-identified cases from their practices to a panel of renowned clinical investigators, this case-based series provides clinicians with practical management strategies and perspectives on the challenges of clinical decision-making.
Episodes
-
Non-Hodgkin Lymphoma — Fourth Annual National General Medical Oncology Summit
12/05/2025 Duration: 50minClinical investigators discuss available data guiding the management of non-Hodgkin lymphoma. CME information and select publications here.
-
Gynecologic Cancers — Fourth Annual National General Medical Oncology Summit
11/05/2025 Duration: 48minClinical investigators discuss available data guiding the management of gynecologic cancers. CME information and select publications here.
-
Non-Hodgkin Lymphoma — An Interview with Dr John P Leonard on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
09/05/2025 Duration: 52minDr John P Leonard from Weill Cornell Medicine in New York, New York, reviews data presented at the 2024 ASH Annual Meeting and their implications for the treatment of non-Hodgkin lymphomas. CME information and select publications here.
-
Breast Cancer — Year in Review Series on Relevant New Datasets and Advances
05/05/2025 Duration: 59minDr Rebecca Dent from National Cancer Centre Singapore and Dr Nancy Lin from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss important efficacy and safety data from 2024 related to the management of localized and advanced breast cancers. CME information and select publications here.
-
Chronic Lymphocytic Leukemia — Year in Review Series on Relevant New Datasets and Advances
02/05/2025 Duration: 59minDr Jennifer R Brown from Dana-Farber Cancer Institute in Boston and Prof Paolo Ghia from IRCCS Ospedale San Raffaele in Milano, Italy, summarize clinically relevant research findings and datasets over the past year regarding the treatment of chronic lymphocytic leukemia. CME information and select publications here.
-
EGFR Mutation-Positive NSCLC — Fourth Annual National General Medical Oncology Summit
30/04/2025 Duration: 52minClinical investigators discuss available data guiding the management of EGFR mutation-positive non-small cell lung cancer. CME information and select publications here.
-
Prostate Cancer — Fourth Annual National General Medical Oncology Summit
29/04/2025 Duration: 47minClinical investigators discuss available data guiding the management of prostate cancers. CME information and select publications here.
-
Immune Thrombocytopenia — A Roundtable Discussion on Current and Future Management Strategies
28/04/2025 Duration: 01h56minDr Hanny Al-Samkari from Massachusetts General Hospital in Boston, Dr James B Bussel from Weill Cornell School of Medicine in New York, New York, and Prof Nichola Cooper from Hammersmith Hospital Campus in London, United Kingdom, share expert perspectives on the diagnosis of and optimal management strategies for immune thrombocytopenia. CME information and select publications here.
-
Biliary Tract Cancers — Fourth Annual National General Medical Oncology Summit
27/04/2025 Duration: 48minClinical investigators discuss available data guiding the management of biliary tract cancers. CME information and select publications here.
-
Oncology Nursing Edition: Antibody-Drug Conjugates for Breast Cancer and Lung Cancer — Proceedings from the 2025 Annual ONS Congress
26/04/2025 Duration: 01h33minDr Edward B Garon, Dr Tiffany A Traina, and nurse practitioners Ms Marianne J Davies and Ms Marissa Marti-Smith discuss the role of antibody-drug conjugates in the care of patients with breast and lung cancer and strategies to mitigate and manage treatment-emergent adverse events. NCPD information and select publications here.
-
Hormone Receptor-Positive Metastatic Breast Cancer — An Interview with Dr Adam M Brufsky on the Impact of Biomarkers and Existing Comorbidities on the Selection of First-Line Therapy
23/04/2025 Duration: 52minDr Adam M Brufsky from the University of Pittsburgh discusses first-line treatment selection for patients with HR-positive metastatic breast cancer and preexisting medical conditions. CME information and select publications here.
-
Genitourinary Cancers — An Interview with Dr William K Oh on Recent Trial Updates
23/04/2025 Duration: 44minDr William Oh from the Yale Cancer Center in New Haven, Connecticut, discusses recent updates on available and novel treatment strategies for genitourinary cancers. CME information and select publications here.
-
Relapsed/Refractory Follicular Lymphoma Part 1 — A Roundtable Discussion on the Selection and Sequencing of Bispecific Antibodies
22/04/2025 Duration: 37minDr Carla Casulo from Wilmot Cancer Institute in Rochester, New York, Dr Matthew Matasar from Rutgers Cancer Institute of New Jersey in New Brunswick and Dr Laurie H Sehn from BC Cancer Centre for Lymphoid Cancer in Vancouver discuss recent updates on available and novel treatment strategies for relapsed/refractory follicular lymphoma. CME information and select publications here.
-
HER2-Positive and Triple-Negative Breast Cancer — Fourth Annual National General Medical Oncology Summit
21/04/2025 Duration: 01h39minClinical investigators discuss available data guiding the management of HER2-positive, triple-negative and localized breast cancer. CME information and select publications here.
-
Oncology Nursing Update Special 2-Part Edition: Bispecific Antibodies in Lymphoma — Part 2
18/04/2025 Duration: 58minNurse practitioner Ms Amy Goodrich from The Sidney Kimmel Comprehensive Care Center in Baltimore, Maryland, presents cases from her practice illustrating the efficacy and safety of bispecific antibodies for non-Hodkin lymphoma. NCPD information and select publications here.
-
Ovarian Cancer — Proceedings from a Session Held During the 2025 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer®️
17/04/2025 Duration: 01h29minDr Kathleen Moore, Dr Ritu Salani, Dr Shannon Westin and moderator Dr Angeles Alvarez Secord share their perspectives and summarize recently presented data from the SGO 2025 annual meeting guiding the management of ovarian cancer. CME information and select publications here.
-
Myelofibrosis — An Interview with Dr Raajit K Rampal on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
15/04/2025 Duration: 43minDr Raajit K Rampal from Memorial Sloan Kettering Cancer Center in New York, New York, discusses recent updates on available and novel treatment strategies for myelofibrosis. CME information and select publications here.
-
Sarcoma and Other Connective Tissue Neoplasms — Fourth Annual National General Medical Oncology Summit
14/04/2025 Duration: 51minClinical investigators discuss available data guiding the management of sarcoma and other connective tissue neoplasms. CME information and select publications here.
-
HR-Positive Breast Cancer — Fourth Annual National General Medical Oncology Summit
13/04/2025 Duration: 01h59minClinical investigators discuss available data guiding the management of hormone receptor-positive metastatic breast cancer. CME information and select publications here.
-
Chronic Lymphocytic Leukemia — Fourth Annual National General Medical Oncology Summit
12/04/2025 Duration: 50minClinical investigators discuss available data guiding the management of chronic lymphocytic leukemia. CME information and select publications here.